The molecular blueprint of targeted radionuclide therapy
(öffnet in neuem Fenster)
Autoren:
Irina Primac, Kevin Tabury, Alpaslan Tasdogan, Sarah Baatout, Ken Herrmann
Veröffentlicht in:
Nature Reviews Clinical Oncology, Ausgabe 22, 2025, ISSN 1759-4774
Herausgeber:
Springer Science and Business Media LLC
DOI:
10.1038/S41571-025-01069-Z
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
(öffnet in neuem Fenster)
Autoren:
Anita Florit, Elizabeth J. de Koster, Serena Sassano, Lejla Alic, Giusi Pisano, Floris H. P. van Velden, Salvatore Annunziata, Irina Primac, Maria Rosaria Ruggiero, Cristina Müller, Evis Sala, Wolfgang P. Fendler, Giovanni Scambia, Lioe-Fee de Geus-Oei, Anna Fagotti, Vittoria Rufini, Angela Collarino
Veröffentlicht in:
European Journal of Nuclear Medicine and Molecular Imaging, Ausgabe 52, 2025, ISSN 1619-7070
Herausgeber:
Springer Science and Business Media LLC
DOI:
10.1007/S00259-025-07277-0